Diabetes Mellitus, Obesity
Conditions
Brief summary
Diabetes related to obesity (diabesity) is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays. However, the pharmacological treatment of diabesity has made significant progress in recent years. The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include: 1. to determine the prevalence of causes and duration of hospitalization 2. to investigate the treatments used 3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.
Interventions
OTHERRoutine care for people with diabetes, with or without obesity, in the hospital setting
Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.
Sponsors
Hospital de Cascais Dr. José de Almeida (Portugal)
Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria)
Rabin Medical Center
Hospital Regional de Malaga
Charles University, Czech Republic
University Hospital Bratislava
Complejo Hospitalario de Especialidades Juan Ramón Jimenez
Medical University Innsbruck
Aristotle University Of Thessaloniki
Rostov State Medical University
Hospital Marina Baixa
Riga East Clinical University Hospital
University Hospital, Aachen
San Raffaele University Hospital, Italy
Kanuni Sultan Suleyman Training and Research Hospital
Medical University of Vienna
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hospitalized at the time of the survey for any cause * Diabetes diagnosis (Known / documented in medical history or newly diagnosed using ADA diagnostic criteria) * Age ≥ 18 years * Written informed consent
Exclusion criteria
* Patients in wards and units other than internal medicine wards (such as outpatient areas, emergency departments, skilled nursing and intensive care units, etc.) * Paediatric patients (Age \< 18 years) * Patients without a diabetes diagnosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of point-of-care glucose values | 3 days | Mean number of point-of-care glucose measurements during hospitalization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Severe hypoglycaemia | From day of admission to the day of data collection, i.e., November 14, 2024 | Severe hypoglycaemia during admission (glucose \<40mg/dL) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Diabetes treatment during hospitalization | From day of admission to the day of data collection, i.e., November 14, 2024 | Diabetes treatment used during the time of hospitalization |
| Insulin regimen during hospitalization | From day of admission to the day of data collection, i.e., November 14, 2024 | Insulin regimen used during the time of hospitalization (e.g., correction, basal, prandial bolus) |
Countries
Austria, Czechia, Germany, Greece, Israel, Latvia, Russia, Turkey (Türkiye)
Outcome results
None listed